Schizophrenia and Bipolar Affective Disorder: Perspectives for the Development of Therapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|3|5|393-407

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.3, Iss.5, 2003-08, pp. : 393-407

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cellular Pathology in the Dorsolateral Prefrontal Cortex Distinguishes Schizophrenia from Bipolar Disorder

By  

Current Molecular Medicine, Vol. 3, Iss. 5, 2003-01 ,pp. : 427-436

Bentham Science Publishers

Access to resources Recommend Favorite

Exposure to Perinatal Infections and Bipolar Disorder: A Systematic Review

By  

Current Molecular Medicine, Vol. 16, Iss. 2, 2016-02 ,pp. : 106-118

Bentham Science Publishers

Access to resources Recommend Favorite

Current Technological Development of Antibody Therapeutics

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 11, Iss. 1, 2011-03 ,pp. : 21-32

Bentham Science Publishers

Access to resources Recommend Favorite

The Comorbidity of Bipolar Disorder and Migraine: The Role of Inflammation and Oxidative and Nitrosative Stress

By  

Current Molecular Medicine, Vol. 16, Iss. 2, 2016-02 ,pp. : 179-186

Bentham Science Publishers

Access to resources Recommend Favorite

Fibromyalgia and Bipolar Disorder: Emerging Epidemiological Associations and Shared Pathophysiology

By  

Current Molecular Medicine, Vol. 16, Iss. 2, 2016-02 ,pp. : 119-136

Bentham Science Publishers

Access to resources Recommend Favorite